Your contact persons

CHEPLAPHARM Arzneimittel GmbH


Active ingredient :

CilazaprilCilazapril / Hydrochlorothiazide

Therapeutic area :


INHIBACE® is a classical angiotensin-converting enzyme (ACE) inhibitor with active substance cilazapril. It is indicated in the treatment of hypertension and chronic heart failure.

INHIBACE® PLUS further contains the combination with hydrochlorothiazide and is indicated in the treatment of hypertension in patients not responding satisfactorily to each component administered alone.

ACE inhibitors in combination with other anti-hypertensives like beta-blockers, calcium channel antagonists, angiotensin receptor blockers, diuretics, thiazides etc. are commonly used in clinical practice. According to clinical practice guidelines, ACE inhibitors are generally considered as first line therapy for hypertension.

Back chevron_right
Back to topexpand_less